Evidence Synthesis
BENCHMARK 14.93% accelerated to, up from 6.15%.
The stock's .15% moved up from .13%. Revenue growth slowed to .8%, down from .7%. The market saw to . Close price rose to .86 INR, up from .81 INR.
Evidence Synthesis
Last synthesized: 21 Oct 2026, 03:53
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
BENCHMARK 14.93% accelerated to, up from 6.15%.
The stock's .15% moved up from .13%. Revenue growth slowed to .8%, down from .7%. The market saw to . Close price rose to .86 INR, up from .81 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 14.93 % | 6.15 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.15 % | 5.13 | ▲ |
| REVENUE_GROWTH_YOY | 52.8 % | 180.7 | ▼ |
| PRICE_CHANGE_PERCENT | 0.107 % | — | - |
| DAILY_VOLUME | 6,000 shares | 4,666 | ▲ |
| CLOSE_PRICE | 46.86 INR | 46.81 | ▲ |
Cite this
Source: Samhati evidence synthesis for BENCHMARK (2026-10-21). Observation: BENCHMARK 14.93% accelerated to, up from 6.15%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/benchmark
Filing step-changes